Shopping Cart
- Remove All
- Your shopping cart is currently empty
Nocloprost (SH 475) is a prostaglandin E2 (PGE2) analog, an EP1 and EP3 receptor agonist with local gastric protection and ulcer healing activity, reducing aspirin-induced gastrointestinal lesions, and inducing platelet activation, useful for studying cardiovascular diseases.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
100 μg | $153 | 35 days | |
500 μg | $415 | 35 days | |
1 mg | $590 | 35 days |
Description | Nocloprost (SH 475) is a prostaglandin E2 (PGE2) analog, an EP1 and EP3 receptor agonist with local gastric protection and ulcer healing activity, reducing aspirin-induced gastrointestinal lesions, and inducing platelet activation, useful for studying cardiovascular diseases. |
In vitro | In platelet-rich citrate plasma, Nocloprost (> 0.1 mumol/l) causes aggregation of biphasic processes at higher concentrations. Nocloprost activation of platelets is accompanied by thromboxen A2 formation and an increase in cytoplasmic calcium in platelets containing Indo 1. Nocloprost(0.1 μM/L) enhanced aggregation induced by low concentrations of ADP or adrenaline. [2] |
In vivo | Nocloprost (0.01-100 μg/kg, intragastric administration) is dose-dependent in preventing the formation of gastric lesions. Nocloprost (0.01-100 μg/kg, gavage) did not affect gastric acid secretion or intestinal secretion in rats, but prevented the increase of gastroduodenal alkaline secretion. [1] |
Alias | ZK94726, ZK84726, ZK 94726, ZK 84726, SH475, SH 475 |
Molecular Weight | 400.98 |
Formula | C22H37ClO4 |
Cas No. | 79360-43-3 |
Smiles | C(=C/[C@H](C(CCCC)(C)C)O)\[C@@H]1[C@@H](C/C=C\CCCC(O)=O)[C@H](Cl)C[C@H]1O |
Relative Density. | 1.1g/cm3 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.